These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9801703)

  • 1. Treatment of psoriasis with troglitazone therapy.
    Pershadsingh HA; Sproul JA; Benjamin E; Finnegan J; Amin NM
    Arch Dermatol; 1998 Oct; 134(10):1304-5. PubMed ID: 9801703
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Morioka S; Akasaka T; Yoshida K
    Am J Cardiol; 2002 Feb; 89(3):318-22. PubMed ID: 11809434
    [No Abstract]   [Full Text] [Related]  

  • 3. Troglitazone in progesterone derivative-induced impairment of glucose tolerance.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 2000 Apr; 39(4):348-9. PubMed ID: 10801159
    [No Abstract]   [Full Text] [Related]  

  • 4. Learning to use troglitazone.
    Riddle MC
    Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
    [No Abstract]   [Full Text] [Related]  

  • 5. Troglitazone: monotherapy indication.
    Lisi DM
    Arch Intern Med; 1998 Feb; 158(4):412. PubMed ID: 9487241
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of troglitazone measured by insulin resistance index.
    Nagasaka S; Iwamoto Y; Ishikawa S; Kuzuya T; Saito T
    Lancet; 1997 Jul; 350(9072):184. PubMed ID: 9250189
    [No Abstract]   [Full Text] [Related]  

  • 7. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 8. Troglitazone: a new antihyperglycemic agent.
    Vidt DG; Speerhas RA; Reddy SS
    Cleve Clin J Med; 1997 May; 64(5):238-40. PubMed ID: 9149473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone directly increases HDL cholesterol levels.
    Nozue T; Michishita I; Minagawa F; Genda A
    Diabetes Care; 1999 Feb; 22(2):355-6. PubMed ID: 10333957
    [No Abstract]   [Full Text] [Related]  

  • 10. Troglitazone and small low-density lipoprotein in type 2 diabetes.
    Hirano T; Yoshino G; Kazumi T
    Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of troglitazone in type 2 diabetes mellitus.
    Gorson DM
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696655
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of troglitazone in type 2 diabetes mellitus.
    Rusk MH
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696656
    [No Abstract]   [Full Text] [Related]  

  • 13. LDL cholesterol and troglitazone therapy.
    Howard BV; Howard WJ
    Diabetes Care; 1998 Dec; 21(12):2201-3. PubMed ID: 9839127
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
    Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
    Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
    [No Abstract]   [Full Text] [Related]  

  • 15. Is troglitazone a real indication for obese subjects with impaired glucose tolerance?
    Yoshioka K; Yokoo S; Yoshida T; Kondo M
    Diabetes Care; 1997 Aug; 20(8):1340-1. PubMed ID: 9250469
    [No Abstract]   [Full Text] [Related]  

  • 16. New diabetes drug targets insulin resistance.
    Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
    [No Abstract]   [Full Text] [Related]  

  • 17. Troglitazone.
    Santiago JV
    Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary edema associated with troglitazone therapy.
    Hirsch IB; Kelly J; Cooper S
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787
    [No Abstract]   [Full Text] [Related]  

  • 19. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus.
    Minamikawa J; Yamauchi M; Inoue D; Koshiyama H
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1041-2. PubMed ID: 9506772
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential interaction of troglitazone and cyclosporine.
    Kaplan B; Friedman G; Jacobs M; Viscuso R; Lyman N; DeFranco P; Bonomini L; Mulgaonkar SP
    Transplantation; 1998 May; 65(10):1399-400. PubMed ID: 9625027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.